News

• Biogen stocks rise on new Alzheimer drug breakthrough
  12/05/2019 / 19:26 - TeleTrader
•  
• Biogen Announces Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)
  12/03/2019 / 13:30 - GlobeNewswire
•  
• Biogen Presents Data Demonstrating Improved Gastrointestinal Tolerability With VUMERITY™ (diroximel fumarate) Compared to TECFIDERA® (dimethyl fumarate)
  11/22/2019 / 13:30 - GlobeNewswire
•  
• Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study for an Inherited Retinal Disorder
  11/21/2019 / 13:30 - GlobeNewswire
•  
• AZTherapies Announces Appointment of Ernest D. Penachio as Vice President of Manufacturing Operations and CMC
  11/06/2019 / 22:05 - GlobeNewswire
•  
• Biogen to Expand Biosimilars Portfolio and Gain Access to Additional Markets Through New Transaction with Samsung Bioepis
  11/06/2019 / 13:30 - GlobeNewswire
•  
• Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer’s Disease (CTAD) Congress on December 5, 2019
  11/04/2019 / 22:30 - GlobeNewswire
•  
• Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
  10/30/2019 / 12:30 - GlobeNewswire
•  
• Biogen stock skyrockets 37% after positive earnings
  10/22/2019 / 15:52 - TeleTrader
•  
• Biogen Q3 revenue $3.6B, up 5% YoY
  10/22/2019 / 12:57 - TeleTrader
•  
• Biogen and Samsung Bioepis to Present Data for Infliximab and Adalimumab Biosimilars at United European Gastroenterology Week
  10/21/2019 / 13:30 - GlobeNewswire
•  
• Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board
  10/02/2019 / 14:20 - GlobeNewswire
•  
• Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZA® (nusinersen) Published in Neuromuscular Disorders
  10/02/2019 / 13:30 - GlobeNewswire
•  
• Biogen Announces Leadership Update
  10/01/2019 / 14:00 - GlobeNewswire
•  
• Interferon Beta Treatments, Including PLEGRIDY® (peginterferon beta-1a) and AVONEX® (interferon beta-1a), Receive Positive CHMP Opinion for Use During Pregnancy and Breastfeeding
  09/23/2019 / 09:00 - GlobeNewswire